Blemiderm Catalougue EN

KFDABL0020/2309 mesoestetic Pharma Group, s.l. C/ Tecnologia, 25 8840 - Viladecans (Barcelona) Tel. +34 933 252 030 www.mesoestetic.com made in Spain 1. INF487. BU. Informe de estudio de biodistribución de transetosomas para acné en explante cutáneo [Report on the study of the biodistribution of transethosomes for acne using skin explants.] Biotechnology Unit. mesoestetic Pharma Group S.L. 2022. 2. INF460. BU. Informe aumento FOXO1 en sebocitos tratados con retinol-neem-enoxolona [Report on the increase in FOXO1 in sebocytes treated with retinol-neem-enoxolone]. Biotechnology Unit. mesoestetic Pharma Group S.L. 2022. 3. with retinol-neem-enoxolone]. Biotechnology Unit. mesoestetic Pharma Group S.L. 2022. 4. INF462. BU. Informe de la vía hormonal en sebocitos tratados con retinol-neem-enoxolona [Report on the hormonal pathway in sebocytes treated with retinol-neem-enoxolone]. Biotechnology Unit. mesoestetic Pharma Group S.L. 2022. 5. Goodarzi A, Mostafarpoor S, Bonaghabadi M, Mohaadi M. The potential of probiotics for treating acne vulgaris: A review of literature on acne and microbiota. Dermatol Ther. 2020 May; 33 (3): e13279. doi: 10,1111/Dth.13279. Epub 2020 Apr 7. 6. Informe del estudio in vitro de la actividad antimicrobiana de blemiderm® caps [Report on the In vitro study on the antimicrobial activity of blemiderm® caps]. Biotechnology Unit. mesoestetic Pharma Group S.L. 2022. 7. INF468. BU. Report on the inhibition of sebum production with EGCG and Australian Maclura. Biotechnology Unit. mesoestetic Pharma Group S.L. 2022. 8. 9. 10. INF470. BU. Informe de la activación de autofagia en sebocitos tratados con retinol y Maclura Australiana [Report on the activation of autophagy in sebocytes treated with retinol and Maclura cochinchinensis]. Biotechnology Unit. mesoestetic Pharma Group S.L. 2022. 11. INF469. BU. Informe de la renovación epidérmica en queratinocitos tratados con retinol y Maclura Australiana [Report on epidermal rejuvenation in keratinocytes treated with retinol and Maclura cochinchinensis]. Biotechnology Unit. mesoestetic Pharma Group S.L. 2022. 12. S. epidermidis y C. acnes 13. Formulas developed to degrees of blemishes caused by acne. Solutions based on the innovations on acne development. Complexes containing exclusive active substances and vehiculation systems Formulas designed to correct, regulate and prevent the appearance of blemishes caused by acne, restoring the quality of the skin. SOLUTIONS